4//SEC Filing
Tasker Sybil 4
Accession 0001012975-17-000722
CIK 0001326190other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 6:37 PM ET
Size
5.6 KB
Accession
0001012975-17-000722
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2017-09-22+50,000→ 50,000 totalExercise: $2.48Exp: 2027-09-22→ Common Stock, par value $0.0001 (50,000 underlying)
Footnotes (1)
- [F1]On the first anniversary of the date of grant, 25% of the unvested portion of the option will become vested and exercisable, and the aggregate remaining unvested portion will vest and become exercisable in equal monthly installments over the 36-month period following such anniversary date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705900
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 6:37 PM ET
- Size
- 5.6 KB